Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares were up 14.2% during trading on Wednesday . The company traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares traded hands during mid-day trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) shares rose 14.2% during trading on Wednesday . The stock traded as high as $6.20 and last traded at $6.20. Approximately 1,553,016 shares changed hands during trading, a decline of 16% from the average daily volume of 1,845,939 shares. The stock had previously closed at $5.43. Wall […]
Editas Medicine, Inc. (NASDAQ:EDIT – Get Free Report) CEO Gilmore Neil O’neill sold 12,191 shares of the company’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $5.50, for a total value of $67,050.50. Following the sale, the chief executive officer now owns 315,279 shares of the […]
Top 10 Publicly Owned Gene Editing Therapy Companies genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.